Piper Sandler lowered the firm’s price target on Elanco (ELAN) to $12 from $16 following the company’s earnings report. The firm keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco Animal Health: Undervalued Growth Potential with Strong Product Performance and Debt Reduction
- Elanco’s Earnings Call: Growth Amid Challenges
- Cautious Hold Rating on Elanco Animal Health Amid Uncertain Growth Prospects
- Elanco price target lowered to $13 from $14 at Morgan Stanley
- Elanco price target lowered to $15 from $16 at Stifel